Effect of electro-acupuncture on substance P, its receptor and corticotropin-releasing hormone in rats with irritable bowel syndrome

World Journal of Gastroenterology

Volumn 15, Issue 41, 2009, Pages 5211-5217

  Xiao Peng, Ma ^a   Tan, Lin Ying ^a   Yang, Yun ^a   Wu, Huan Gan ^a   Jiang, Bin ^a   Liu, Hui Rong ^a   Yang, Ling ^a  

^a Shanghai Institute of Acupuncture Moxibustion and Meridian   (China)

Author keywords

Corticotropin releasing hormone; Electro acupuncture; Irritable bowel syndrome; Substance P; Substance P receptor

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; SUBSTANCE P; SUBSTANCE P RECEPTOR; TOLONIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON DILATATION; COLON MUCOSA; CONTROLLED STUDY; DOWN REGULATION; ELECTROACUPUNCTURE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IRRITABLE COLON; MALE; MAST CELL; NONHUMAN; PROTEIN EXPRESSION; RANDOMIZATION; RAT; SCORING SYSTEM; SPRAGUE DAWLEY RAT; STIMULATION; THERAPY EFFECT; VISCERA; WITHDRAWAL REFLEX;

EID: 73449103544     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.5211     Document Type: Article

References (36)

1. Jones J, Boorman J, Cann P, Forbes A, Gomborone J, Heaton K, Hungin P, Kumar D, Libby G, Spiller R, Read N, Silk D, Whorwell P. British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut 2000; 47 Suppl 2: ii1-ii19
2. Torii A, Toda G. Management of irritable bowel syndrome. Intern Med 2004; 43: 353-359
3. Talley NJ. Irritable bowel syndrome. Intern Med J 2006; 36: 724-728
4. Liu HR, Yang Y, Wu HG. Clinical Study on Acupuncture in Treating Diarrhea-predominant Irritable Bowel Syndrome. J Acupunct Tuina Sci 2008; 6: 360-362
5. Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut 1992; 33: 825-830
6. Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut 2000; 47: 861-869
7. Aggarwal A, Cutts TF, Abell TL, Cardoso S, Familoni B, Bremer J, Karas J. Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterology 1994; 106: 945-950
8. Munakata J, Mayer EA, Chang L, Schmulson M, Liu M, Tougas G, Kamath M, Naliboff B. Autonomic and neuroendocrine responses to recto-sigmoid stimulation. Gastroenterology 1998; 114: A808
9. Taché Y, Martinez V, Million M, Rivier J. Corticotropinreleasing factor and the brain-gut motor response to stress. Can J Gastroenterol 1999; 13 Suppl A: 18A-25A
10. Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 1998; 42: 845-849
11. Lembo T, Plourde V, Shui Z, Fullerton S, Mertz H, Tache Y, Sytnik B, Munakata J, Mayer E. Effects of the corticotropinreleasing factor (CRF) on rectal afferent nerves in humans. Neurogastroenterol Motil 1996; 8: 9-18
12. Mayer EA, Naliboff BD, Chang L, Coutinho SV. V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2001; 280: G519-G524
13. Yang Y, Zhou D, Zhang W. [Mast cells of ileocecal junction in irritable bowel syndrome] Zhonghua Neike Zazhi 1997; 36: 231-233
14. Ansel JC, Brown JR, Payan DG, Brown MA. Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 1993; 150: 4478-4485
15. Al-Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 2000; 119: 1276-1285
16. Williams CL, Villar RG, Peterson JM, Burks TF. Stressinduced changes in intestinal transit in the rat: a model for irritable bowel syndrome. Gastroenterology 1988; 94: 611-621
17. Videlock EJ, Chang L. Irritable bowel syndrome: current approach to symptoms, evaluation, and treatment. Gastroenterol Clin North Am 2007; 36: 665-685, x
18. Fukudo S, Suzuki J. Colonic motility, autonomic function, and gastrointestinal hormones under psychological stress on irritable bowel syndrome. Tohoku J Exp Med 1987; 151: 373-385
19. Fukudo S, Nomura T, Muranaka M, Taguchi F. Brain-gut response to stress and cholinergic stimulation in irritable bowel syndrome. A preliminary study. J Clin Gastroenterol 1993; 17: 133-141
20. Frank L, Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C. Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther 2002; 24: 675-689; discussion 674
21. Okano S, Nagaya H, Ikeura Y, Natsugari H, Inatomi N. Effects of TAK-637, a novel neurokinin-1 receptor antagonist, on colonic function in vivo. J Pharmacol Exp Ther 2001; 298: 559-564
22. Martínez V, Wang L, Rivier JE, Vale W, Taché Y. Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. J Pharmacol Exp Ther 2002; 301: 611-617
23. Williams CL, Peterson JM, Villar RG, Burks TF. Corticotropin-releasing factor directly mediates colonic responses to stress. Am J Physiol 1987; 253: G582-G586
24. Barouei J, Adams MC, Hodgson DM. Prophylactic role of maternal administration of probiotics in the prevention of irritable bowel syndrome. Med Hypotheses 2009; 73: 764-767
25. Andresen V, Camilleri M. Irritable bowel syndrome: recent and novel therapeutic approaches. Drugs 2006; 66: 1073-1088
26. Gareau MG, Jury J, MacQueen G, Sherman PM, Perdue MH. Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut 2007; 56: 1522-1528
27. García-Ródenas CL, Bergonzelli GE, Nutten S, Schumann A, Cherbut C, Turini M, Ornstein K, Rochat F, Corthésy-Theulaz I. Nutritional approach to restore impaired intestinal barrier function and growth after neonatal stress in rats. J Pediatr Gastroenterol Nutr 2006; 43: 16-24
28. Gareau MG, Jury J, Perdue MH. Neonatal maternal separation of rat pups results in abnormal cholinergic regulation of epithelial permeability. Am J Physiol Gastrointest Liver Physiol 2007; 293: G198-G203
29. Eutamene H, Bueno L. Role of probiotics in correcting abnormalities of colonic flora induced by stress. Gut 2007; 56: 1495-1497
30. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R. A role for inflammation in irritable bowel syndrome? Gut 2002; 51 Suppl 1: i41-i44
31. Ringel Y, Sperber AD, Drossman DA. Irritable bowel syndrome. Annu Rev Med 2001; 52: 319-338
32. Dong WZ, Zou DW, Li ZS, Zou XP, Zhu AY, Xu GM, Yin N, Gong YF, Sun ZX, Man XH. Study of visceral hypersensitivity in irritable bowel syndrome. Chin J Dig Dis 2004; 5: 103-109
33. Wang WF, Yang YS, Peng LH, Sun G. Alternation of substance P-containing neural pathways in a rat model of irritable bowel syndrome with rectal distension. Chin J Dig Dis 2006; 7: 211-218
34. Dong WZ, Zhou XP, Zhou DW, Li ZS, Xu GM, Zhou AY, Gong YF. The relationship between mast cell and neuropeptide fibre of colonic mucous membrane in irritable bowel syndrome. Dier Junyi Daxue Xuebao 2003; 24: 147-150
35. Park CH, Joo YE, Choi SK, Rew JS, Kim SJ, Lee MC. Activated mast cells infiltrate in close proximity to enteric nerves in diarrhea-predominant irritable bowel syndrome. J Korean Med Sci 2003; 18: 204-210
36. Wu HG, Jiang B, Zhou EH, Shi Z, Shi DR, Cui YH, Kou ST, Liu HR. Regulatory mechanism of electroacupuncture in irritable bowel syndrome: preventing MC activation and decreasing SP VIP secretion. Dig Dis Sci 2008; 53: 1644-1651